Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma

PURPOSE: To evaluate the safety and efficacy of a modified administration schedule of docetaxel, cisplatin, and fluorouracil (mDCF) with bevacizumab in patients with advanced gastroesophageal malignancies. PATIENTS AND METHODS: Previously untreated patients with metastatic gastroesophageal adenocarc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Shah, Manish A., Jhawer, Minaxi, Ilson, David H., Lefkowitz, Robert A., Robinson, Edric, Capanu, Marinela, Kelsen, David P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2011
Schlagworte:
Original Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3646322/
https://ncbi.nlm.nih.gov/pubmed/21189380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.0770
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge